Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA)

Historical Holders from Q2 2024 to Q3 2025

Symbol
KNSA on Nasdaq
CUSIP
G52694109
Type / Class
Equity / Common Stock
Shares outstanding
43.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
40.8M
Holdings value
$1.58B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
197
Number of buys
103
Number of sells
-98
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rubric Capital Management LP 9.24% +14.9% $100M $13.5M 3.91M +15.6% RUBRIC CAPITAL MANAGEMENT LP Jun 30, 2025
VANGUARD GROUP INC 7.04% $119M 3.06M The Vanguard Group Sep 30, 2025
TANG CAPITAL MANAGEMENT LLC 5.2% $44.4M 2.18M TANG CAPITAL MANAGEMENT, LLC Mar 28, 2025
BlackRock, Inc. 1% -88% $10.7M -$47.2M 418K -81.5% BlackRock, Inc. Jun 30, 2025

Institutional Holders of Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 40.8M $1.58B +$45.2M $38.83 197
2025 Q2 39.7M $1.1B +$4.33M $27.67 185
2025 Q1 39.9M $885M +$25.3M $22.21 172
2024 Q4 38.9M $770M -$20.6M $19.78 156
2024 Q3 39.5M $987M +$125M $24.99 173
2024 Q2 35.2M $658M +$656M $18.67 125